Chemomab Therapeutics Ltd. Proceeds from Sale of Treasury Stock
Chemomab Therapeutics Ltd. (CMMB) reported Proceeds from Sale of Treasury Stock of $0 for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfTreasuryStock · last filed 2026-03-23
| Period end | Proceeds from Sale of Treasury Stock | Proceeds from Sale of Treasury Stock 1 month | Proceeds from Sale of Treasury Stock 12 month |
|---|---|---|---|
| 2025-12-31 | $0.00 20-F · filed 2026-03-23 | ||
| 2024-12-31 | $0.00 20-F · filed 2026-03-23 | ||
| 2023-12-31 | $580.00K 20-F · filed 2026-03-23 | ||
| 2023-11-17 | $580.00K 20-F · filed 2026-03-23 | $580.00K 20-F · filed 2025-04-04 | |
| 2022-12-31 | $0.00 20-F · filed 2025-04-04 | ||
| 2021-12-31 | $0.00 20-F · filed 2024-03-28 |